companydata.dkNordre Fasanvej 216 Komplementarselskab ApS: Financial statements 2023
CVR: 41236078
Nordre Fasanvej 216 Komplementarselskab ApS (CVR 41236078) has filed annual accounts for 2023. In 2023, the company reported revenue of DKK 0 and a net result of DKK 0 compared with DKK 0 the year before. Equity amounted to DKK 33,080. The solvency ratio was 93%.
- Revenue
- 0 kr.
- Gross Profit
- -2,500 kr.
- Profit/Loss
- 0 kr.
- Equity
- 33,080 kr.
- Total Assets
- 35,580 kr.
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2023 | 0 | -3 t. | 0 | 33 t. | - |
| 2022 | - | -3 t. | 0 | 33 t. | - |
| 2021 | - | -3 t. | 0 | 33 t. | - |
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2023
Nordre Fasanvej 216 Komplementarselskab ApS has published its annual report for 2022. Gross profit came to DKK -2,500, and the net result was DKK 0.
About Nordre Fasanvej 216 Komplementarselskab ApS
Nordre Fasanvej 216 Komplementarselskab ApS is a Danish company of the type Anpartsselskab based in Aarhus C, founded in 2020. The company is registered under the industry Ikke-finansielle holdingselskaber. The management consists of Erik Wihlborg. The company's owners include ARKMEDIC ApS, Lene Agersnap and Morten Haaning Charles. In 2025, the company reported a gross profit of DKK 875 and a net result of DKK 1,226 compared with DKK 752 the year before. Equity amounted to DKK 35,058.